Exhibit 23.1
The Stockholders and Board of Directors
Unigene Laboratories, Inc.:
We consent to the use of our report included herein and to the reference to our
firm under the headings "Selected Financial Data" and "Experts" in the
prospectus. Our report dated March 17, 2000 contains an explanatory paragraph
that states that Unigene Laboratories, Inc. has suffered recurring losses from
operations and has a working capital deficiency which raise substantial doubt
about its ability to continue as a going concern. The financial statements do
not include any adjustments that might result from the outcome of this
uncertainty.
/s/ KPMG LLP
Short Hills, New Jersey
December 26, 2000
